Dulaglutide or Tirzepatide? Worldwide Biopharma Changes
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine ...
Beyond the Paywall: The Cost of Lack of Research Access
One of the small ironies of modern medical research reveals itself during a routine PubMed search. A promising article appears, ...
To Fix a Patient’s Irregular Heartbeat, Doctors First Tested Its Digital ‘Twin’
Scientists created virtual replicas of patients' diseased hearts so precise that blocking a dangerous irregular heartbeat in these digital "twins" ...
An Unusual Case of Pneumonia on ‘The Pitt’: An Emergency Doctor Weighs In
As "The Pitt" continues its second season, MedPage Today takes a closer look at the series through the perspective of ...
Young Adults With Hypertension Have 27% Higher Risk
Share on PinterestHigh blood pressure in people ages 30 to 40 may increase the risk of cardiovascular disease later in ...
Chelsea and Westminster Hospital uses augmented reality before endometriosis surgery
The hospital is using augmented reality, a technology that overlays digital images onto the real world, during pre-surgical consultations to ...
Mono and MS: New Research Deepens Link
Epstein-Barr virus (EBV)-positive infectious mononucleosis was linked to a more than threefold increase in MS risk.The study analyzed people with ...
Here’s How Many Doctors and Nurses Are Getting Flu or COVID Shots
Over three-fourths of healthcare workers received an influenza vaccine in 2024-2025, survey data showed.COVID vaccination was less common, at 40%, ...
Raw Dairy Farm Recalls Cheese Products as FDA Investigates E. Coli Outbreak
A California dairy producer that health authorities have been investigating amid an ongoing outbreak of E. coli is recalling some ...
Trump’s Budget Again Calls for Billions in NIH Cuts
Proposed cuts of $5 billion in NIH funding and $129 million to the Agency for Healthcare Research and Quality (AHRQ) ...
Novel Therapies for Hidradenitis Suppurativa Produce Rapid, Deepening Responses
DENVER -- Two therapeutic candidates for severe hidradenitis suppurativa (HS) achieved major responses that proved durable in randomized trials reported ...
Multiple Drugs Flagged for Higher C. Diff Risk
Commonly prescribed antibiotics and non-antibiotic drugs were associated with significantly increased odds of Clostridioides difficile infection in a case-control study.Non-antibiotic ...
Novel Agent for Alopecia Areata Appears Safe, Effective
A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe alopecia areata. Medscape Medical News ...
Oncology Care Model’s Net Losses Well Exceed Savings
But the CMS’s cancer-focused alternative payment model’s losses “mask successes” that should serve as lessons, experts say. Medscape Medical News ...
Cancer Warning for Processed Meats? Vaping and Lung Cancer; ‘Playful’ Trial Acronyms
The Physicians Committee for Responsible Medicine has petitioned the Department of Agriculture to require a colon cancer warning on labels ...
Trump Unveils 100% Tariff on Some Patented Drugs
President Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented ...
Strength Training Potentially Beneficial in Patients With HS
Development of validated interventions and guidance for physical therapists and dermatologists — and HS patients themselves — is a goal. ...
Drug Boosts PSMA-PET Signal for Prostate Cancer in Small Study
A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a subset of patients ...
Therapy Linked to Lower Death Risk in Serious Tick-Borne Illness
Guidelines recommend red blood cell exchange transfusion for selected patients with severe babesiosis, though this recommendation is backed by "low-quality ...
Tailoring Vaccine Conversations to Patient Values and Risk Factors
Developed in partnership with the Our Partner In "Beyond Diagnosis: Vaccines," Cleveland Clinic infectious disease specialist Donald Dumford III, MD, ...
